WASHINGTON--(BUSINESS WIRE)--The Association of Clinical Research Organizations (ACRO), which represents the global leaders in clinical outsourcing, today released the following statement in recognition of World Heart Day.
“Last year, ACRO member companies conducted nearly 600 clinical trials of new drugs and treatments for cardiovascular disease involving 230,000 patients around the world,” said Doug Peddicord, PhD, Executive Director. “According to the World Heart Association, 17.1 million people die each year from cardiovascular disease, 80 percent of whom are in developing countries. These sobering numbers highlight the importance of not only conducting further research into cardiovascular disease but also ensuring this research is carried out globally.”
About ACRO
The Association of Clinical Research Organizations (ACRO) represents companies whose focus is clinical research. The association provides an active voice for the global CRO industry, which provides specialized services that are integral to the discovery and development of drugs, biologics, vaccines and medical devices. Through its member companies, ACRO helps improve the quality, efficiency and safety of biomedical research. ACRO member companies employ approximately 72,000 professionals worldwide and last year conducted more than 11,500 clinical trials involving nearly 2 million participants in 114 countries. For more information, please visit www.acrohealth.org.